Öhman L

Exposure of Colon-Derived Epithelial Monolayers to Fecal Luminal Factors from Patients with Colon Cancer and Ulcerative Colitis Results in Distinct Gene Expression Patterns.

Magnusson MK, Bas Forsberg A, Verveda A, ..., Simrén M, Öhman L

Int J Mol Sci 25 (18) - [2024-09-13; online 2024-09-13]

Bioinformatics Support and Infrastructure [Collaborative] Bioinformatics Support, Infrastructure and Training [Collaborative] Chalmers Mass Spectrometry Infrastructure [Collaborative]

Temporal stability of fecal metabolomic profiles in irritable bowel syndrome.

Iribarren C, Savolainen O, Sapnara M, ..., Magnusson MK, Öhman L

Neurogastroenterol. Motil. 36 (3) e14741 [2024-03-00; online 2024-01-19]

Chalmers Mass Spectrometry Infrastructure [Collaborative]

Fecal Luminal Factors from Patients with Gastrointestinal Diseases Alter Gene Expression Profiles in Caco-2 Cells and Colonoids.

Holst LM, Iribarren C, Sapnara M, ..., Magnusson MK, Öhman L

Int J Mol Sci 23 (24) - [2022-12-07; online 2022-12-07]

Chalmers Mass Spectrometry Infrastructure [Collaborative]

Differences in Metabolite Composition of Aloe barbadensis Mill. Extracts Lead to Differential Effects on Human Blood T Cell Activity In Vitro.

Ahluwalia B, Magnusson MK, Larsson F, ..., Ross AB, Öhman L

Molecules 27 (19) - [2022-10-06; online 2022-10-06]

Chalmers Mass Spectrometry Infrastructure [Service]

Fecal luminal factors from patients with irritable bowel syndrome induce distinct gene expression of colonoids.

Iribarren C, Nordlander S, Sundin J, ..., Simrén M, Öhman L

Neurogastroenterol. Motil. 34 (10) e14390 [2022-10-00; online 2022-04-29]

Chalmers Mass Spectrometry Infrastructure [Service] Integrated Microscopy Technologies Gothenburg [Service]

A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome.

Ahluwalia B, Iribarren C, Magnusson MK, ..., Simrén M, Öhman L

Cells 10 (6) - [2021-06-10; online 2021-06-10]

Chalmers Mass Spectrometry Infrastructure [Service]